1.132 sonuç
· Sayfa 57/57
📅 2026 📈 SJR ≥ 0,5
Excel'e Aktar
Scopus
🏆 Q2 · SJR 0,685
Eugenol attenuates paclitaxel-induced cardiotoxicity by modulating autophagy-related markers in rats
· Cilt 29, s.794-803
Scopus
🏆 Q2 · SJR 0,562 YÖKSİS Eşleşti
Caffeine engineered copper oxide nanostructures as ultra-trace amperometric detector for humic acid through reducible constituents
· Cilt 106, s.2448-2469
Scopus
🏆 Q2 · SJR 0,671 🔓 Açık Erişim YÖKSİS Eşleşti
Just Joint Damage? Situations Affecting Mood in Hemophilia Patients and Their Partners
· Cilt 32, s.1-9
Scopus
🏆 Q3 · SJR 0,523
Effect of 3’,4’-Dihydroxyflavonol on Striatum Antioxidant System in Focal Cerebral Ischemia-Reperfusion of Rat
Scopus
🏆 Q2 · SJR 0,98
Biological and social rhythm differences, daily melatonin secretion and psychiatric symptoms in healthy adults
Scopus
🏆 Q2 · SJR 0,65
Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study
Scopus
🏆 Q1 · SJR 1,119
Campanula cymbalaria var. papillosa: Phytochemical profile, antioxidant activities, enzyme inhibitory effects, antibacterial activity, cytotoxicity, and molecular docking analysis
· Cilt 75
Scopus
🏆 Q1 · SJR 0,949 🔓 Açık Erişim YÖKSİS Eşleşti
Role of Sirtuins in Heat Stress Tolerance under Elevated CO2 in Arabidopsis: Photosynthesis, Antioxidant System and Redox Regulation
Scopus
🏆 Q2 · SJR 0,572 🔓 Açık Erişim YÖKSİS Eşleşti
Organic Photovoltaics Spectral Overlap Prediction Based on Electronic Structure Descriptors and Explainable Machine Learning
· Cilt 2026
Scopus
🏆 Q2 · SJR 0,583
Dramatic Morphometabolic Response to Bevacizumab-Based Chemotherapy After Immunotherapy Failure in Malignant Pleural Mesothelioma on FDG PET
Scopus
🏆 Q1 · SJR 0,845 🔓 Açık Erişim YÖKSİS Eşleşti
Acotiamide Can Be Used as an Anti-Cognitive Disorder Agent in Diseases Associated with Cognitive Dysfunction
· Cilt 46, s.97-105
Scopus
🏆 Q1 · SJR 0,912 🔓 Açık Erişim
EFFECT OF THE MIND DIET ON FATIGUE, QUALITY OF LIFE, AND BRAIN FOG IN PATİENTS WİTH MULTIPLE SCLEROSIS: STUDY PROTOCOL FOR A PARALLEL-GROUP RANDOMIZED CONTROLLED TRIAL